Current Headlines

  1. Abbott Secures Two Catheter-Based Medical Device Companies
    10/30/2014

    Looking to revitalize its medical device business, Abbott Laboratories moved into the fast-growing electrophysiology market by acquiring heart rhythm company Topera Inc. for $250 million upfront. It also secured the right to buy ablation therapy company Advanced Cardiac Therapeutics Inc. in the future for an undisclosed sum.

  2. Wright Medical And Tornier Merge In A $3.3B Tax Inversion
    10/30/2014

    U.S.-based Wright Medical Group and Netherlands-based Tornier have entered into an all-stock inversion deal worth $3.3 billion that will create a new company focusing on three high-growth areas in orthopedics.

  3. New Urine Test Can Detect Cancer In Minutes
    10/30/2014

    A new point-of-care urine test enables the rapid detection of disease markers in urine at extremely low concentrations. The test, which incorporates a new, microfluidic lab-on-a-chip, can detect a disease by analyzing how far a sample travels through the device’s tubing.

  4. Australian Government To Initiate Review Of Medical Device Regulations
    10/30/2014

    A group of experts will review the Australian Therapeutic Goods Administration’s (TGA) framework for the regulation of medical devices and pharmaceuticals, according to a recent government announcement.

  5. Graphene Sensors Stimulate Neurons Optically And Electronically
    10/30/2014

    While electrical sensing is a mainstay of neurological studies, optical methods have recently started to become more prevalent.

  6. Can Bio-Computers Kill Cancer Cells?
    10/30/2014

    New research from ETH Zurich has made progress towards achieving bio-computers by developing a biological circuit that controls individual sensory components.

  7. Researchers Grow New Blood Vessels In Just Seven Days
    10/30/2014

    Researchers from Sahlgrenska Academy have demonstrated the ability to grow a new blood vessel in only a week.

  8. Covidien To Divest Assets Before Medtronic Merger
    10/29/2014

    Covidien plans to sell some assets that are part of its Vascular Therapies line ahead of its planned merger with Medtronic, which is expected to close later this year or in early 2015.

  9. Yale-OPM Joint Research Program To Develop New 3D Printed Biomedical Technologies, Applications
    10/29/2014

    Oxford Performance Materials Inc. (OPM), a leading advanced materials and additive manufacturing (3D printing) company, today announced the commencement of an extensive joint research program with Yale University to develop innovative and cost-effective 3D printed biomedical technologies and applications.

  10. FDA Issues Emergency Use Authorization For Ebola Diagnostic Device
    10/28/2014

    FDA officials recently issued an emergency use authorization (EUA) for Utah-based BioFire Defence’s FilmArray Biothreat-E test for the detection of the Ebola Zaire virus. The test runs and can only be used with the device maker’s FilmArray systems. 

Newsletter Signup
Newsletter Signup
Get the latest medical device industry news, insights, and analysis delivered to your inbox.
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.